VGX-3100 HPV Vaccine

+ 2
Dec 8
4 min read

MD Anderson Launches Phase 2 HPV Vaccine Study

Phase 2 cancer study evaluating T cell-activating immunotherapy MEDI0457 with MedImmune’s durvalumab targeting several HPV-related cancers
moon shine reflecting in lake
Cancer
Sexually Transmitted Diseases
HPV